Facilitating the research of numerous nationally and internationally recognized scientists, in over sixty labs across British Columbia, to improve cancer care.

BC Cancer Research strives to improve the lives of patients through the integration of basic biomedical research, genomics, clinical trials, health services research, cancer surveillance, population health, and the development of innovative new technology, programs, and interventions. Organized through departments and programs with various themes, BC Cancer supports groundbreaking cancer research and personalized care approaches through world-class facilities and platforms including genomics, bioinformatics, imaging, drug development and tissue banking.

Our Research

At BC Cancer, collaboration is at the root of every discovery and breakthrough that impacts patient care. Our 2024 Research Report showcases the many achievements at BC Cancer that were a result of our priority to integrate research and cancer care, and continue collaborations with local, national and international partners.

Read the 2024 BC Cancer Research Report

News & Events

Florian Kuchenbauer and Peter Stirling receive 2025 Cancer Research Society 2025 Operating Grants

Two BC Cancer researchers are recipients of 2025 Operating Grants from the Cancer Research Society.

Dr. Florian Kuchenbauer received a grant for the project, “Targeting APOBEC3B-induced replication stress in multiple myeloma with TP53 abnormalities.”

Dr. Peter Stirling received a grant for the project, “Inhibiting DNA2 nuclease for selective killing of ALT positive cancers.”

Research Recovery Resources

BC Cancer Research is taking a gradual and careful approach to re-opening research activities to protect our staff, patients and communities.

Access our COVID-19 recovery resources.

Our Strategic Plan

Our Strategic Plan outlines our direction to strengthen our research capabilities and collaboration with departments and partners to improve our ability to generate knowledge, enhance the impact of our research, and support innovation in clinical care.  

Read the BC Cancer Research Strategic Plan.

Publications

Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference Workshops.

Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2025
Wallace, Paul K, Jellison, Evan R, Thornton, Sherry, Kluepfel, Kathleen, Back, Jessica, Beadnell, Thomas C, Bebes, Attila, Behrends, Jochen, Belkina, Anna C, Black, Michele, Bogdanoski, Goce, Bollati-Fogolín, Mariela, Bonte, Sarah, Van der Borght, Katrien, Brinkman, Ryan R, Brundage, Kathleen, Bushnell, Tim, Chiu, Daniel T, Chow, Norman, Ciccolella, Christopher O, Cochran, Matthew, Czechowska, Kamila, Dagla, Kleopatra, Daniel, Benjamin, de la Cruz, Gelo, Van Duyse, Julie, Font, Laura Ferrer, Fornas, Òscar, Garcia-Garcia, Sara, Gardner, Rui, Van Gassen, Sofie, Gimenes, Daniel, Grenfell, Richard, Grider-Hayes, Madeline J, Grose, Randall, Hall, Christopher, Hally, Kathryn E, Hameetman, Marjolijn, Hogg, Karen, Houston, Jessica, Irish, Jonathan M, Isterdael, Gert Van, Jaimes, Maria, Janetzki, Sylvia, Kim, Cheryl, Koladiya, Abhishek, Lamote, Jochen, Lannigan, Joanne, Leconte, Julien, Litwin, Virginia, Longhini, Ana, Loof, Nicolas, Lozano-Andrés, Estefanía, Lundsten, Kelly, Mage, Peter, Mair, Florian, Martins, Catarina Gregório, McCausland, Megan, McGuire, Helen M, Meskas, Justin, Murphy, William, Nolan, John, Oliveira, Barbara, Ordoñez-Rueda, Diana, Orlowski-Oliver, Eva, Petersen, Charlotte Christie, Poulton, Nicole J, Putri, Givanna, Quadrini, Karen J, Ramasz, Beata, Ruhrmund, Donald, Singh, Vikas V, Small, Sam J, Smith, Natalie J, Spidlen, Josef, Stegen, Camille, Tak, Tamar, Thompson, Sam, Thomson, Michael, Vocelle, Daniel, Walker, Rachael V, Walsh, Robin E, Wang, Lili, Wang, Yu-Fen, Weglarz, Meredith, Winker, Moritz, Wood, James C S, Woolard, Stacie, Yeh, Nai-Yu, Yuecel, Raif, Rajwa, Bartek

Higher promoter methylation of the Ubiquitin Associated and SH3 domain containing A (UBASH3A) gene is associated with T-lymphocyte ontogeny and reduced susceptibility to early-onset sepsis.

The Journal of infectious diseases, 2025
Wang, Ziyi, Amenyogbe, Nelly, Ben-Othman, Rym, Cai, Bing, Lo, Mandy, Idoko, Olubukola T, Odumade, Oludare A, Falsafi, Reza, Blimkie, Travis M, An, Andy, Shannon, Casey P, Montante, Sebastiano, Dhillon, Bhavjinder K, Diray-Arce, Joann, Ozonoff, Al, Smolen, Kinga K, Brinkman, Ryan R, McEnaney, Kerry, Angelidou, Asimenia, Richmond, Peter, Tebbutt, Scott J, Kampmann, Beate, Hancock, Robert E W, Lee, Amy H Y, Levy, Ofer, Kollmann, Tobias R, Martino, David
Back to top